Home / Latest news
Keep up to date with the latest news from Accelagen

Meet the Study Startup (SSU) team at Accelagen
Discover how the Study Startup (SSU) team at Accelagen is leading clinical trial initiation with innovation, collaboration, and a commitment to patient-centric solutions.
Meet Chris Goon: Head of Medical Affairs at Accelagen
Learn what Accelagen’s Head of Medical Affairs, Dr Chris Goon, is doing to keep the team adaptable and grounded in clinical reality.
Meet Madeleine Reynard: The Organisational Force behind Accelagen
Find out what Accelagen’s EA and Office Manager, Madeleine Reynard, loves about her role keeping our fast-growing team connected and organised.
Delivering a Data-Driven Future at Accelagen: Meet Janus and Jessie
Spotlighting our Data Management team—meet Janus Rowlan D. Relos and Jessie Lourdesamy, as they drive innovation and excellence in clinical data solutions.
Why Regulatory Affairs is the Backbone of Accelagen’s Expertise: Introducing Our Newest Regulatory Affairs Officers, Adriana Paola Camargo
As we expand our Regulatory Affairs team, learn how Accelagen is enhancing expertise in regulatory strategy, market authorisation, and patient impact.
New Faces, New Frontiers: Meet Accelagen’s Newest Clinical Project Managers
Introducing two of Accelagen’s new Clinical Project Managers, driving innovation in rare disease and global clinical trials.
Welcoming Ano Chinogurei as Accelagen’s People & Culture Lead
Learn how Accelagen’s new Head of People & Culture, Ano Chinogurei, is shaping a people-first culture, and leveraging tech to drive growth & engagement.
How Accelagen’s Medical Team is elevating clinical trial excellence
How Accelagen’s Medical Team is elevating clinical trial excellence Accelagen’s medical team is growing, strengthening our capabilities in pharmacovigilance, medical writing, and clinical oversight for safer, smarter trials.Accelagen is in an exciting phase of growth, with our medical team expanding…
Leading the future of Biostatistics at Accelagen: Meet our experienced new Head of Biostatistics, Rebecca Asher
Leading the future of Biostatistics at Accelagen: Meet our experienced new Head of Biostatistics, Rebecca Asher Australia’s biotech sector is growing rapidly, and Accelagen is proud to be leading the way. Meet our experienced new Head of Biostatistics, Rebecca Asher.Behind…